XIGEN

xigen-logo

Xigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland. Dr. Christophe Bonny, CEO and co-founder, is a renowned molecular biologist with over a decade's research expertise on intracellular peptides and signalling.

#SimilarOrganizations #People #Financial #Website #More

XIGEN

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2002-01-01

Address:
Epalinges, Vaud, Switzerland

Country:
Switzerland

Website Url:
http://www.xigenpharma.com

Total Employee:
11+

Status:
Active

Contact:
41213211081

Email Addresses:
[email protected]

Total Funding:
41 M USD

Technology used in webpage:
Google Apps For Business AJAX Libraries API Gandi.net DNS


Similar Organizations

marinomed-logo

Marinomed

Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.

Current Employees Featured

christophe-bonny_image

Christophe Bonny
Christophe Bonny Co-Founder & CSO @ Xigen
Co-Founder & CSO

Founder


christophe-bonny_image

Christophe Bonny

peter-harboe-schmidt_image

Peter Harboe Schmidt

Investors List

tilocor-life-science_image

Tilocor Life Science

Tilocor Life Science investment in Series B - Xigen

initiative-capital_image

Initiative Capital

Initiative Capital investment in Series A - Xigen

vi-partners_image

VI Partners

VI Partners investment in Series A - Xigen

tilocor-life-science_image

Tilocor Life Science

Tilocor Life Science investment in Series A - Xigen

Official Site Inspections

http://www.xigenpharma.com Semrush global rank: 5.44 M Semrush visits lastest month: 1.56 K

Unable to get host informations!!!

Loading ...

More informations about "Xigen"

Tigen Pharma - Crunchbase Company Profile & Funding

Tigen Pharma is a biotech company that specializes in the field of cell and gene therapy ecosystems.See details»

Tigen Company Profile 2024: Valuation, Funding

Tigen General Information Description. Operator of a biotechnology company intended to provide cell therapy products to cure cancer. The company specializes in bridging the gap between academic and commercially ready โ€ฆSee details»

Xigen Company Profile 2024: Valuation, Funding & Investors

Xigen General Information Description. Developer of innovative therapeutic peptides designed to be used against inflammation. The company's peptides have metabolic stability, and specificity โ€ฆSee details»

ABOUT - Tigen Pharma

We are a Swiss biotech company with the vision to accelerate the access to novel therapies for patients and society. We scout for disruptive ideas, catalyse the science with state-of-the-art โ€ฆSee details»

Xigen - Crunchbase Company Profile & Funding

Xigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland.See details»

Tigen Pharma SA โ€“ Swiss Biotech

Tigen is a Swiss clinical stage biotech company developing cell therapies to cure cancer. A disruptive catalyst, combining a unique culture with a multidisciplinary set of world-class โ€ฆSee details»

Tigen Pharma - Biopôle

We are a Swiss biotech company with the vision to accelerate the access to novel therapies for patients and society. We scout for disruptive ideas, catalyse the science with state-of-the-art โ€ฆSee details»

Xigen SA - Drug pipelines, Patents, Clinical trials - Synapse - Patsnap

Nov 1, 2024 The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase โ€ฆSee details»

Tigen Pharma SA Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Tigen Pharma SA of Lausanne, VAUD. Get the latest business insights from Dun & Bradstreet.See details»

Tigen Pharma - VentureRadar

"Tigen Pharma is a science company focused on accelerating the access to novel T cell therapies for solid tumours. They collaborate with leading institutions to advance cell therapies from idea โ€ฆSee details»

Xigen - VentureRadar

Similar Companies: Immunocore United Kingdom Publicly Traded We are a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new โ€ฆSee details»

Xigen - Company Profile - Tracxn

Nov 26, 2024 Xigen is developing therapeutic peptides for a broad range of diseases, with a focus on inflammation. Its technology platform, Xigen ICPT enables the design and synthesis โ€ฆSee details»

Xigen Company Profile - Office Locations, Competitors, Revenue

Xigen has 5 employees at their 1 location and $41 m in total funding,. See insights on Xigen including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆSee details»

Tigen Pharma SA at the Swiss Biotech Day

Home; Sponsorship Opportunities; Registration; On Site; Attendees. Attendees 2024; Attendees 2023; Attendees 2022; Attendees 2021; Attendees 2019; Attendees 2018See details»

TEAM - Tigen Pharma

We are different and every employee is unique. A multidisciplinary team with extensive industry expertise. We go deep to come up with new ideas for scientific and technical breakthrough.See details»

Tigen Pharma SA, Lausanne | Contacts & emails - business โ€ฆ

Website: www.tigenpharma.com. NOGA codes: A NOGA code is a standardized system for classifying businesses and economic activities. The primary use of NOGA codes is to organize โ€ฆSee details»

SCIENCE - Tigen Pharma

We are a science company with the vision to accelerate the access to novel T cell therapies to fight liquid and solid tumours. We partner with leading institutions to take cell therapies to the โ€ฆSee details»

Advancing Oncology Innovation: Celebrating One Year of Pfizer

4 days ago Pfizer has a longstanding commitment to advancing innovative cancer treatments to help improve outcomes for patients worldwide. One year ago, Pfizerโ€™s acquisition of Seagen โ€ฆSee details»

CAREER | Tigen Pharma

We are driven by future possibilities. A highly collaborative team of experts challenging existing standards and routines. Weโ€™re committed to building a diverse team, embracing an inclusive โ€ฆSee details»

NEWS - Tigen Pharma

We are moving fast and shaping the cell & gene landscape requires a lot of engagement amongst all stakeholders in the ecosystem. We keep you informed about the latest news on Tigen and โ€ฆSee details»

linkstock.net © 2022. All rights reserved